RE: RE: Try This Again... Hey Casa,
Inhibitex has a few drugs in the works. None are more advanced than phase II. If success comes from GAP in phase I, then it's possible to take it in different directions towards other cancers (as long as financial resources are there). That would form a pipeline of drugs and that is where the best multiples come from in regards to valuation. Tough to predict how long it would take until it's shown whether a pipeline is going to happen or not.
First things first, we'll see what the results are from OHRI. That will provide the formula to mass produce in prep for the required toxicity testing.